Quick Stats
Listing Price
83
(5.06%)
Subscription
7.27x
Allotment Status
Out
Last Updated
27-03-2026 10:46 AM
Gaudium IVF and Women Health IPO Live Subscription Status & Investor Quota
Track the live subscription status of Gaudium IVF and Women Health IPO with detailed QIB, NII, and Retail subscription data. Get real-time updates on investor demand, subscription trends, and market sentiment to evaluate IPO performance before listing.
Analyze category-wise participation, day-wise subscription movement, and overall demand to better understand how Gaudium IVF and Women Health IPO is performing in the primary market.
Investor Quota & Reservation Details
NII
15%
QIB
50%
Retail
35%
Subscription Analysis
As of the latest update, the Gaudium IVF and Women Health IPO is subscribed 7.27x overall. Higher participation observed across investor categories. The highest participation is seen in the Non-Institutional Investors (NII) category, subscribed 14.05x. Retail investors have also participated actively with 7.6x subscription. To understand how current market sentiment is reflected, check the latest Gaudium IVF and Women Health IPO GMP.
Gaudium IVF and Women Health IPO Subscription Status
Category-wise subscription status
Total Subscription
7.27x
Leading Segment
NII
Last updated: 24-02-2026 06:00 PM
Gaudium IVF and Women Health IPO has a total of 1,46,20,340 equity shares. The remaining shares are distributed among public investors as follows: QIB (excluding Anchor) are allotted 41,77,240 shares (28.57%), Non-Institutional Investors (NII) have 31,32,930 shares (21.43%), and Retail Individual Investors (RII) are allotted 73,10,170 shares (50.00%).
Gaudium IVF and Women Health IPO Category-Wise Subscription Details (Live)
| Category | Offered | Bid For | Sub (x) |
|---|---|---|---|
| QIB (Excl. Anchor Shares) | 41,77,240 | 67,85,478 | 1.62x |
| NII | 31,32,930 | 4,40,22,069 | 14.05x |
| Retail | 73,10,170 | 5,55,42,942 | 7.60x |
| Total | 1,46,20,340 | 10,63,50,489 | 7.27x |
Note: Subscription figures are calculated based on net public issue shares. Anchor investor and market maker shares are excluded from public bidding.
Day-wise Subscription Trend
| Date | Day | QIB | NII | Retail | Total |
|---|---|---|---|---|---|
| 20 Feb | Day 1 | - | 0.91x | 1.37x | 0.88x |
| 23 Feb | Day 2 | 0.02x | 4.62x | 4.00x | 3.00x |
| 24 Feb | Day 3 | 1.62x | 14.05x | 7.60x | 7.27x |
Understanding Mainboard IPO Subscription
Qualified Institutional Buyers (QIB)
QIBs include mutual funds and banks. A high QIB subscription in Gaudium IVF and Women Health IPO signals strong confidence from big players in the company's long-term valuation.
Non-Institutional Investors (NII)
Non-Institutional Investors (NII) or HNIs bid for amounts over ₹2 Lakhs. Aggressive bidding for Gaudium IVF and Women Health IPO in this category often indicates interest from savvy investors seeking listing gains.
Retail Individual Investors (RII)
Retail investors can apply for Gaudium IVF and Women Health IPO with a minimum investment of around ₹15,000. High retail numbers here show general public excitement.